Cystic Fibrosis Diagnostic Tests Market Size by Type, End-user, Region, Industry-Wide Analysis, Competitive Landscape Assessment & Long-Term Forecast to 2034
Overview
The Cystic Fibrosis Diagnostic Tests Market size was valued at USD 5.47 Billion in 2025 and the total Cystic Fibrosis Diagnostic Tests revenue is expected to grow at a CAGR of 4% from 2026 to 2034, reaching nearly USD 7.79 Billion.
Cystic Fibrosis Diagnostic Tests Market Introduction and Overview
Cystic Fibrosis is an inherited disease, which causes severe damage to the lungs, digestive system, and other organs in the body. It is an autosomal recessive, monogenetic disorder caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. These mutations lead to alterations in protein, causing thick mucus to build up in the lungs and other organs. This causes difficulty in breathing and accumulation of mucus. Germs can thrive on the accumulated mucus causing infection, inflammation and severe respiratory damage.
The increased prevalence of Cystic Fibrosis has led to an increase in the test market. Currently, available tests are new-born screening, Chest X-ray, sweat test, lung functions test, and genetic testing. FDA approval for Trikafta (elexacaftor/ivacaftor/tezacaftor) drug in 2022 boosted the CF tests market by over $1 Bn. The total sales were driven up by 29% to $1.6 Bn.
Cystic Fibrosis Diagnostic Tests Market Size, Growth & Share Analysis
To know about the Research Methodology :- Request Free Sample Report
Gene Therapy could offer a comprehensive cure for cystic fibrosis- Innovations in delivering genetic sequences and gene replacement therapies are helping the market to gain momentum. In addition to this, funding’s from non-profit organizations for research and partnerships of top players for developing advanced gene therapies are aiding the market growth at a fast rate. Companies are scouting for new tools and technologies and in the process to boost their product pipelines which in turn will help the market grow.
The report covers the detailed analysis of global Cystic Fibrosis Diagnostic Tests market with the classifications of the market based on test type, End-users, and region. Analysis of past market dynamics from 2020 to 2025 is given in the report, which will help readers to benchmark the past trends with current market scenarios with the key players contribution in it.
The report has profiled twenty four key players in the market from different regions. However, report has considered all market leaders, followers and new entrants with investors while analysing the market and estimation the size of the same. The growing healthcare infrastructure in each region is different and focus is given on availability of advanced technology and new techniques. Report has come up with recommendations for future hot spot in APAC region. New research findings, funding policies for projects and its impact on CF Diagnostic Tests market are covered ion the report.
Cystic Fibrosis Diagnostic Tests Market Segment Analysis
The market for Test Type is expected to grow at a CAGR of xx% during the forecast period. The need for diagnosis of the condition at the primary stage is important. The increase in the prevalence of this condition will lead to a rise in the number of tests performed, thereby driving the market growth.
Cystic Fibrosis Diagnostic Tests Market Regional Analysis
North America is expected to contribute a dominant share in the market due to an increase in awareness about Cystic Fibrosis, low test costs, and highly developed infrastructure followed by Europe by 2034.
Whereas in the APAC region, the market is likely to grow at a CAGR of xx% during the forecast period. Increasing cases of patients with inflammatory bowel diseases and developing healthcare infrastructure are elevating the market.
The objective of the report is to present a comprehensive analysis of the global market of all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analysed, which will give a clear futuristic view of the industry to the decision-makers.
The report also helps in understanding global market dynamics, structure by analysing the market segments and project the global market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in global market make the report investor’s guide.
Cystic Fibrosis Diagnostic Tests Market Recent Industry Developments
| Date | Company | Development | Impact |
|---|---|---|---|
| 15 January 2025 | Quest Diagnostics | Expanded its advanced CFTR gene mutation panel to improve carrier screening and early diagnostic accuracy. | Enhances diagnostic precision and reduces turnaround times for pediatric cystic fibrosis testing. |
| 10 February 2025 | Illumina Inc. | Launched a next-generation sequencing-based assay optimized for comprehensive cystic fibrosis variant detection. | Drives adoption of high-throughput genetic testing across clinical laboratories globally. |
| 04 March 2025 | Vertex Pharmaceuticals | Announced strategic research funding and partnership to support next-generation gene editing diagnostic tools. | Accelerates innovations in molecular testing workflows for rare genetic respiratory conditions. |
| 22 April 2025 | Abbott Laboratories | Received CE mark expansion for its high-precision diagnostic testing systems integrated with pulmonary function tracking. | Strengthens the company's European market footprint in integrated respiratory disease management. |
Cystic Fibrosis Diagnostic Tests Market Scope: Inquire before buying
| Cystic Fibrosis Diagnostic Tests Market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2025 | Forecast Period: | 2026-2034 |
| Historical Data: | 2020 to 2025 | Market Size in 2025: | USD 5.47 Bn. |
| Forecast Period 2026 to 2034 CAGR: | 4% | Market Size in 2034: | USD 7.79 Bn. |
| Segments Covered: | by Type | Genetic Tests Faecal Test Immunoreactive Trypsinogen (IRT) Test Sweat Chloride Tests Pulmonary function Tests |
|
| by End-user | Hospitals Diagnostics Laboratories Others |
||
Cystic Fibrosis Diagnostic Tests Market, by Region
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)
Cystic Fibrosis Diagnostic Tests Market Key Players:
1. Quidel Corporation
2. Quest Diagnostics
3. Vertex Pharmaceuticals
4. Verona Pharma
5. Abbott Laboratories
6. Pfizer Inc
7. Novartis
8. Creative Diagnostics
9. Invitae Corporation
10. Asper Biogene
11. GeneDx
12. Illumina Inc
13. Elucigene Diagnostics
14. BillionToOne Inc
15. ELITech Group
16. NovaBiotics Ltd
17. Cystic Fibrosis Foundation Therapeutics, Inc
18. Galapagos NV
19. AbbVie
20. Gilead Sciences
21. F.Hoffman La Roche
22. Forest Laboratories
23. Genentech
24. Pharmaxis
Frequently Asked Questions:
1. Which region has the largest share in Global Cystic Fibrosis Diagnostic Tests Market?
Ans: North America region held the highest share in 2025.
2. What is the growth rate of Global Cystic Fibrosis Diagnostic Tests Market?
Ans: The Global Cystic Fibrosis Diagnostic Tests Market is growing at a CAGR of 4% during forecasting period 2026-2034.
3. What is scope of the Global Cystic Fibrosis Diagnostic Tests Market report?
Ans: Global market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.
4. Who are the key players in Global Cystic Fibrosis Diagnostic Tests Market?
Ans: The important key players in the Global Cystic Fibrosis Diagnostic Tests Market are – Quidel Corporation, Quest Diagnostics, Vertex Pharmaceuticals, Verona Pharma, Abbott Laboratories, Pfizer Inc, Novartis, Creative Diagnostics, Invitae Corporation, Asper Biogene,
5. What is the study period of this Market?
Ans: The Global Cystic Fibrosis Diagnostic Tests Market is studied from 2020 to 2034.